Immune evasion by staphylococci

By T. Foster. Nature Reviews Microbiology, 2005

1,318 citations recorded by the source corpus.

Subfields: Infectious Diseases, Microbiology, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/72d30fb77d5a82d7ec5851cb6bbd12f81a7529d7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Infectious Diseases

In Microbiology

In Molecular Biology

Citations in the corpus

Characterization of a new cytotoxin that contributes to Staphylococcus aureus pathogenesis (2010, background): “aureus depends partly on the production of an extensive repertoire of exoproteins and cell wallanchored proteins that allow the organism to evade the innate immune system (Foster, 2005; Nizet, 2007; Graves et al., 2010).”
Pathogenesis of methicillin-resistant Staphylococcus aureus infection. (2008, background): “aureus may also secrete chemotaxis inhibitory protein of staphylococci or the extracellular adherence protein, which interfere with neutrophil extravasation and chemotaxis to the site of infection (reviewed by Foster [16]).”
Staphylococcus aureus CC398: Host Adaptation and Emergence of Methicillin Resistance in Livestock (2012, background): “The human innate immunomodulatory genes carried by Sa3 prophages play crucial roles in human niche adaptation (19, 20), whereas the Av -carried SAAV_2008 and SAAV_2009 genes (encoding a putative ornithine cyclodeaminase and a putative membrane protease of the CAAX family, respectively) belong to the”
Bacteriophage resistance mechanisms (2010, background): “gov/sites/entrez?Db=genomeprj&cmd=ShowDetailView&TermToSearch=12304"> Staphylococcus aureus produces a cell-wall-anchored virulence factor, immunoglobulin G-binding protein A , which binds to the Fc fragment of immunoglobulin”
Complement System Part II: Role in Immunity (2015, background): “Staphylococcal protein A (SpA) recognizes the Fc portion of Igs with high affinity and hide the binding site for C1q, thus blocking the initiation of the CP (169).”
Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology (2018, background): “Many factors contribute to the success of this pathogen; however, its capacity to persist as a commensal, its ability to combat multiple antimicrobial agents, and its multitude of virulence determinants, often with redundant functions, are among the most important contributors (105, 451, 452).”
Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications (2010, background): “and abundantly expressed in infections of the lung (83).”
The Bicomponent Pore-Forming Leucocidins of Staphylococcus aureus (2014, background): “eration of multicomponent therapeutics and vaccines (22, 23).”
Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria. (2019, background): “Many phage bind to protein structures on the bacteria such as pili (red; e.g., Mindich et al., 1976), flagella (yellow; e.g., Choi et al., 2013), porins (blue; e.g., Furukawa and Mizushima, 1982), or efflux pumps (purple; e.g., Chan et al., 2016).”
Staphylococcus aureus Elaborates Leukocidin AB To Mediate Escape from within Human Neutrophils (2013, background): “aureus has evolved an extensive armamentarium devoted to counteracting PMNs (46, 47), including the bicomponent leukotoxins LukAB, LukED, PVL, and HlgACB (10, 11).”